ETFS Holding Pharmacyclics, Inc.

 
ETFS Holding Pharmacyclics, Inc. top ^
  • Holdings: Top Holdings IWM More..., Pharmacyclics, Inc., Ocwen Financial Corporation, Starwood Property Trust, Inc., 3D Systems Corporation, Alaska Air Group, Inc.
  • Category: Small Blend
  • Morningstar Rating: 3 Stars
Sign-up for iwm investment picks
  • Holdings: Top Holdings IWO More..., Pharmacyclics, Inc., 3D Systems Corporation, Genesee & Wyoming, Inc. Class A, Alaska Air Group, Inc., Alkermes PLC
  • Category: Small Growth
  • Morningstar Rating: 3 Stars
Sign-up for iwo investment picks
  • Holdings: Top Holdings VTWG More..., Pharmacyclics, Inc., Alaska Air Group, Inc., Genesee & Wyoming, Inc. Class A, CommVault Systems, Inc., Axiall Corp
  • Category: Small Growth
Sign-up for vtwg investment picks
  • Holdings: Top Holdings VTWO More..., Alaska Air Group, Inc., Two Harbors Investment Corp, Pharmacyclics, Inc., Axiall Corp, Genesee & Wyoming, Inc. Class A
  • Category: Small Blend
Sign-up for vtwo investment picks

 
Stock Quotes for Pharmacyclics, Inc. top ^
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Speculative Growth
Sign-up for pcyc investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Speculative Growth
Sign-up for pcyc investment picks

 
News Articles for Pharmacyclics, Inc. top ^
2013/3/8
SUNNYVALE, Calif.
Sign-up for Pharmacyclics, Inc. Prices Public Offering of Common Stock investment picks
2013/3/7
SUNNYVALE, Calif.
Sign-up for Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock investment picks
2013/2/14
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012 investment picks
2013/2/21
ABBOTT PARK, Ill., Feb.
Sign-up for Abbott to Collaborate with Janssen and Pharmacyclics on Development of Companion Test for Investigational Leukemia Therapy investment picks
2013/4/8
Pharmacyclics Inc. (PCYC) said the U.S. Food and Drug Administration granted an additional breakthrough-therapy designation for its investigational oral agent ibrutinib as a monotherapy to treat patients with chronic lymphocytic leukemia or small lymphocytic lymphoma with deletion of the short arm of chromosome 17.
Sign-up for Pharmacyclics Gets New Breakthrough-Therapy Designation for Ibrutinib investment picks
2013/4/11
Pharmacyclics Inc. (PCYC) said the enrollment of a fifth patient in a clinical trial triggered a $50 million milestone payment from Johnson & Johnson (JNJ) unit Janssen Biotech Inc. The Phase III trial studies Pharmacyclics's drug ibrutinib versus chlorambucil in elderly patients with newly diagnosed chronic lymphocytic leukemia and small lymphocyctic lymphoma.
Sign-up for Pharmacyclics Gets Fourth $50 Million Milestone Payment from Janssen investment picks
2013/4/11
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study investment picks
2013/4/24
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call investment picks
2013/5/1
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Reports First Quarter 2013 Results investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Pharmacyclics, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding PH Glatfelter Company  |  Next: ETFS Holding Phillips 66